Oneness Biotech Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 1,065.55 million compared to TWD 65.77 million a year ago. Net income was TWD 359.98 million compared to net loss of TWD 403.3 million a year ago.

Basic earnings per share from continuing operations was TWD 0.8174 compared to basic loss per share from continuing operations of TWD 0.9317 a year ago. Diluted earnings per share from continuing operations was TWD 0.7998 compared to diluted loss per share from continuing operations of TWD 0.9317 a year ago.